Pneumococcal Vaccination Atlas

Country Profile: Netherlands

Recommendations

Children:
Children aged 3 to 11 months

At-risk groups:
At-risk groups including people with a medical indication, such as sickle cell anaemia, asplenia and respiratory conditions

Older adults:
Older adults aged 60 to 75, with vaccination every 5 years and a final dose at 75

Coverage figures (2021)

Children: 92.56%

At-risk groups: –

Older adults: –

Vaccination advisory body/committee

The Permanent Committee on Vaccinations

Sources:

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=163

National Institute for Public Health and the Environment: https://www.rivm.nl/en/pneumococci/information-for-policy-makers

Children

WHO: https://immunizationdata.who.int/pages/coverage/pcv.html?CODE=NLD&ANTIGEN=PCV1+PCV2+PCV3&YEAR=

Children

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=163

At-risk groups

Royal Dutch Pharmacy Association: https://www.apotheek.nl/medicijnen/pneumokokkenvaccin#heb-ik-een-recept-nodig

Older adults

ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=163

Report an issue: Something doesn’t look right? Contact us